Literature DB >> 18262679

TLR3: interferon induction by double-stranded RNA including poly(I:C).

Misako Matsumoto1, Tsukasa Seya.   

Abstract

Toll-like receptor 3 (TLR3) recognizes viral double-stranded RNA and its synthetic analog polyriboinosinic:polyribocytidylic acid (poly(I:C)) and induces type I interferon (IFN), inflammatory cytokine/chemokine production and dendritic cell (DC) maturation via the adaptor protein TICAM-1 (also called TRIF). TLR3 is expressed both intracellularly and on the cell surface of fibroblasts and epithelial cells, but is localized to the endosomal compartment of myeloid DCs. Several studies in TLR3-deficient mice demonstrate that TLR3 participates in the generation of protective immunity against some viral infections. Involvement of TLR3-TICAM-1 in activation of NK cells and CTLs by myeloid DCs suggests that TLR3 serves as an inducer of cellular immunity sensing viral infection rather than a simple IFN inducer. In this review, we summarize the current knowledge on TLR3 and discuss its possible role in innate and adaptive immunity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18262679     DOI: 10.1016/j.addr.2007.11.005

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  223 in total

1.  Control of solid tumor growth in mice using EGF receptor-targeted RNA replicase-based plasmid DNA.

Authors:  B Leticia Rodriguez; Xinran Li; Kaoru Kiguchi; John DiGiovanni; Evan C Unger; Zhengrong Cui
Journal:  Nanomedicine (Lond)       Date:  2012-02-02       Impact factor: 5.307

Review 2.  Recent insights into the role of Toll-like receptors in viral infection.

Authors:  M Carty; A G Bowie
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

3.  Toll-like receptor 3 signaling converts tumor-supporting myeloid cells to tumoricidal effectors.

Authors:  Hiroaki Shime; Misako Matsumoto; Hiroyuki Oshiumi; Shinya Tanaka; Akio Nakane; Yoichiro Iwakura; Hideaki Tahara; Norimitsu Inoue; Tsukasa Seya
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-19       Impact factor: 11.205

4.  Innate immune activation by the viral PAMP poly I:C potentiates pulmonary graft-versus-host disease after allogeneic hematopoietic cell transplant.

Authors:  Christine V Kinnier; Tereza Martinu; Kymberly M Gowdy; Julia L Nugent; Francine L Kelly; Scott M Palmer
Journal:  Transpl Immunol       Date:  2010-11-09       Impact factor: 1.708

5.  Adeno-associated virus activates an innate immune response in normal human cells but not in osteosarcoma cells.

Authors:  Leila N Laredj; Peter Beard
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

6.  Mammalian target of rapamycin (mTOR) regulates TLR3 induced cytokines in human oral keratinocytes.

Authors:  Jiawei Zhao; Manjunatha R Benakanakere; Kavita B Hosur; Johnah C Galicia; Michael Martin; Denis F Kinane
Journal:  Mol Immunol       Date:  2010-08-21       Impact factor: 4.407

7.  TLR3 activation efficiency by high or low molecular mass poly I:C.

Authors:  Yu Zhou; Ming Guo; Xu Wang; Jielang Li; Yizhong Wang; Li Ye; Ming Dai; Li Zhou; Yuri Persidsky; Wenzhe Ho
Journal:  Innate Immun       Date:  2012-10-03       Impact factor: 2.680

8.  Regulation of TLR3 Activation by S100A9.

Authors:  Su-Yu Tsai; Jesus A Segovia; Te-Hung Chang; Niraj K Shil; Swechha M Pokharel; T R Kannan; Joel B Baseman; Joan Defrêne; Nathalie Pagé; Annabelle Cesaro; Philippe A Tessier; Santanu Bose
Journal:  J Immunol       Date:  2015-09-18       Impact factor: 5.422

9.  Poly(I:C) adjuvant strongly enhances parasite-inhibitory antibodies and Th1 response against Plasmodium falciparum merozoite surface protein-1 (42-kDa fragment) in BALB/c mice.

Authors:  Akram Abouie Mehrizi; Niloufar Rezvani; Sedigheh Zakeri; Atefeh Gholami; Laleh Babaeekhou
Journal:  Med Microbiol Immunol       Date:  2018-02-03       Impact factor: 3.402

10.  Mouse embryonic stem cells have underdeveloped antiviral mechanisms that can be exploited for the development of mRNA-mediated gene expression strategy.

Authors:  Ruoxing Wang; Chengwen Teng; Joseph Spangler; Jundi Wang; Faqing Huang; Yan-Lin Guo
Journal:  Stem Cells Dev       Date:  2013-12-20       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.